California-based Arrowhead Pharmaceuticals, which has about 100 employees in Madison, signed a deal totaling $673 million with Amgen, one of the world’s largest biotechnology companies, to bring two drugs to market for the treatment of cardiovascular disease.
Get Our Email Newsletter
The companies, people and issues shaping business in Madison and the Capital Region.
